{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T09:42:20Z","timestamp":1790242940950,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T00:00:00Z","timestamp":1562112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T00:00:00Z","timestamp":1562112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U1404310"],"award-info":[{"award-number":["U1404310"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s11010-019-03581-0","type":"journal-article","created":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T14:02:43Z","timestamp":1562162563000},"page":"205-215","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Apelin promotes hepatic fibrosis through ERK signaling in LX-2 cells"],"prefix":"10.1007","volume":"460","author":[{"given":"Ying","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Bo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangyu","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weitong","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0263-5715","authenticated-orcid":false,"given":"Xinrui","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,3]]},"reference":[{"key":"3581_CR1","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3109\/10408363.2011.596521","volume":"48","author":"BW Smith","year":"2011","unstructured":"Smith BW, Adams LA (2011) Non-alcoholic fatty liver disease. Crit Rev Clin Lab Sci 48:97\u2013113. \n                    https:\/\/doi.org\/10.3109\/10408363.2011.596521","journal-title":"Crit Rev Clin Lab Sci"},{"key":"3581_CR2","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1002\/lt.24412","volume":"22","author":"C Venturi","year":"2016","unstructured":"Venturi C, Reding R, Quinones JA, Sokal E, Rahier J, Bueno J, Sempoux C (2016) Relevance of activated hepatic stellate cells in predicting the development of pediatric liver allograft fibrosis. Liver Transpl 22:822\u2013829. \n                    https:\/\/doi.org\/10.1002\/lt.24412","journal-title":"Liver Transpl"},{"key":"3581_CR3","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1172\/JCI66369","volume":"123","author":"C Yin","year":"2013","unstructured":"Yin C, Evason KJ, Asahina K, Stainier DY (2013) Hepatic stellate cells in liver development, regeneration, and cancer. J Clin Invest 123:1902\u20131910. \n                    https:\/\/doi.org\/10.1172\/JCI66369","journal-title":"J Clin Invest"},{"key":"3581_CR4","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1002\/hep.22467","volume":"48","author":"A Principe","year":"2008","unstructured":"Principe A, Melgar-Lesmes P, Fernandez-Varo G, del Arbol LR, Ros J, Morales-Ruiz M, Bernardi M, Arroyo V, Jimenez W (2008) The hepatic apelin system: a new therapeutic target for liver disease. Hepatology 48:1193\u20131201. \n                    https:\/\/doi.org\/10.1002\/hep.22467","journal-title":"Hepatology"},{"key":"3581_CR5","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.yexcr.2017.11.035","volume":"362","author":"Y Chen","year":"2018","unstructured":"Chen Y, Ou Y, Dong J, Yang G, Zeng Z, Liu Y, Liu B, Li W, He X, Lan T (2018) Osteopontin promotes collagen I synthesis in hepatic stellate cells by miRNA-129-5p inhibition. Exp Cell Res 362:343\u2013348. \n                    https:\/\/doi.org\/10.1016\/j.yexcr.2017.11.035","journal-title":"Exp Cell Res"},{"key":"3581_CR6","doi-asserted-by":"publisher","first-page":"10464","DOI":"10.1073\/pnas.0403518101","volume":"101","author":"N De Mota","year":"2004","unstructured":"De Mota N, Reaux-Le Goazigo A, El Messari S, Chartrel N, Roesch D, Dujardin C, Kordon C, Vaudry H, Moos F, Llorens-Cortes C (2004) Apelin, a potent diuretic neuropeptide counteracting vasopressin actions through inhibition of vasopressin neuron activity and vasopressin release. Proc Natl Acad Sci 101:10464\u201310469. \n                    https:\/\/doi.org\/10.1073\/pnas.0403518101","journal-title":"Proc Natl Acad Sci"},{"key":"3581_CR7","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S0167-4889(00)00143-9","volume":"1538","author":"Y Kawamata","year":"2001","unstructured":"Kawamata Y, Habata Y, Fukusumi S, Hosoya M, Fujii R, Hinuma S, Nishizawa N, Kitada C, Onda H, Nishimura O, Fujino M (2001) Molecular properties of apelin: tissue distribution and receptor binding. Biochim Biophys Acta 1538:162\u2013171","journal-title":"Biochim Biophys Acta"},{"key":"3581_CR8","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.ejphar.2015.05.017","volume":"763","author":"C Chaves-Almagro","year":"2015","unstructured":"Chaves-Almagro C, Castan-Laurell I, Dray C, Knauf C, Valet P, Masri B (2015) Apelin receptors: from signaling to antidiabetic strategy. Eur J Pharmacol 763:149\u2013159. \n                    https:\/\/doi.org\/10.1016\/j.ejphar.2015.05.017","journal-title":"Eur J Pharmacol"},{"key":"3581_CR9","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1161\/CIRCULATIONAHA.116.023218","volume":"135","author":"P Yang","year":"2017","unstructured":"Yang P, Read C, Kuc RE, Buonincontri G, Southwood M, Torella R, Upton PD, Crosby A, Sawiak SJ, Carpenter TA, Glen RC, Morrell NW, Maguire JJ, Davenport AP (2017) Elabela\/Toddler is an endogenous agonist of the apelin APJ receptor in the adult cardiovascular system, and exogenous administration of the peptide compensates for the downregulation of its expression in pulmonary arterial hypertension. Circulation 135:1160\u20131173. \n                    https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.023218","journal-title":"Circulation"},{"key":"3581_CR10","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1096\/fj.201600784R","volume":"31","author":"R Gerbier","year":"2017","unstructured":"Gerbier R, Alvear-Perez R, Margathe JF, Flahault A, Couvineau P, Gao J, De Mota N, Dabire H, Li B, Ceraudo E, Hus-Citharel A, Esteoulle L, Bisoo C, Hibert M, Berdeaux A, Iturrioz X, Bonnet D, Llorens-Cortes C (2017) Development of original metabolically stable apelin-17 analogs with diuretic and cardiovascular effects. FASEB J 31:687\u2013700. \n                    https:\/\/doi.org\/10.1096\/fj.201600784R","journal-title":"FASEB J"},{"key":"3581_CR11","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1016\/j.bbadis.2016.11.007","volume":"1863","author":"JC Zhong","year":"2017","unstructured":"Zhong JC, Zhang ZZ, Wang W, McKinnie SMK, Vederas JC, Oudit GY (2017) Targeting the apelin pathway as a novel therapeutic approach for cardiovascular diseases. Biochim Biophys Acta Mol Basis Dis 1863:1942\u20131950. \n                    https:\/\/doi.org\/10.1016\/j.bbadis.2016.11.007","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"3581_CR12","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.peptides.2015.11.002","volume":"75","author":"Y Yang","year":"2016","unstructured":"Yang Y, Zhang XJ, Li LT, Cui HY, Zhang C, Zhu CH, Miao JY (2016) Apelin-13 protects against apoptosis by activating AMP-activated protein kinase pathway in ischemia stroke. Peptides 75:96\u2013100. \n                    https:\/\/doi.org\/10.1016\/j.peptides.2015.11.002","journal-title":"Peptides"},{"key":"3581_CR13","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3389\/fphar.2017.00221","volume":"8","author":"X Lv","year":"2017","unstructured":"Lv X, Kong J, Chen WD, Wang YD (2017) The role of the apelin\/APJ system in the regulation of liver disease. Front Pharmacol 8:221. \n                    https:\/\/doi.org\/10.3389\/fphar.2017.00221","journal-title":"Front Pharmacol"},{"key":"3581_CR14","doi-asserted-by":"publisher","first-page":"e57231","DOI":"10.1371\/journal.pone.0057231","volume":"8","author":"J Chu","year":"2013","unstructured":"Chu J, Zhang H, Huang X, Lin Y, Shen T, Chen B, Man Y, Wang S, Li J (2013) Apelin ameliorates TNF-alpha-induced reduction of glycogen synthesis in the hepatocytes through G protein-coupled receptor APJ. PLoS ONE 8:e57231. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0057231","journal-title":"PLoS ONE"},{"key":"3581_CR15","doi-asserted-by":"publisher","DOI":"10.5009\/gnl14345","author":"YL Lim","year":"2016","unstructured":"Lim YL, Choi E, Jang YO, Cho YZ, Kang YS, Baik SK, Kwon SO, Kim MY (2016) Clinical implications of the serum apelin level on portal hypertension and prognosis of liver cirrhosis. Gut Liver. \n                    https:\/\/doi.org\/10.5009\/gnl14345","journal-title":"Gut Liver"},{"key":"3581_CR16","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1089\/ars.2013.5182","volume":"20","author":"A Drougard","year":"2014","unstructured":"Drougard A, Duparc T, Brenachot X, Carneiro L, Gouaze A, Fournel A, Geurts L, Cadoudal T, Prats AC, Penicaud L, Vieau D, Lesage J, Leloup C, Benani A, Cani PD, Valet P, Knauf C (2014) Hypothalamic apelin\/reactive oxygen species signaling controls hepatic glucose metabolism in the onset of diabetes. Antioxid Redox Signal 20:557\u2013573. \n                    https:\/\/doi.org\/10.1089\/ars.2013.5182","journal-title":"Antioxid Redox Signal"},{"key":"3581_CR17","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.metabol.2009.10.019","volume":"59","author":"CN Ercin","year":"2010","unstructured":"Ercin CN, Dogru T, Tapan S, Kara M, Haymana C, Karadurmus N, Karslioglu Y, Acikel C (2010) Plasma apelin levels in subjects with nonalcoholic fatty liver disease. Metabolism 59:977\u2013981. \n                    https:\/\/doi.org\/10.1016\/j.metabol.2009.10.019","journal-title":"Metabolism"},{"key":"3581_CR18","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s00535-010-0296-3","volume":"46","author":"H Yokomori","year":"2011","unstructured":"Yokomori H, Oda M, Yoshimura K, Machida S, Kaneko F, Hibi T (2011) Overexpression of apelin receptor (APJ\/AGTRL1) on hepatic stellate cells and sinusoidal angiogenesis in human cirrhotic liver. J Gastroenterol 46:222\u2013231. \n                    https:\/\/doi.org\/10.1007\/s00535-010-0296-3","journal-title":"J Gastroenterol"},{"key":"3581_CR19","doi-asserted-by":"publisher","first-page":"5306","DOI":"10.1210\/en.2010-0754","volume":"151","author":"P Melgar-Lesmes","year":"2010","unstructured":"Melgar-Lesmes P, Casals G, Pauta M, Ros J, Reichenbach V, Bataller R, Morales-Ruiz M, Jimenez W (2010) Apelin mediates the induction of profibrogenic genes in human hepatic stellate cells. Endocrinology 151:5306\u20135314. \n                    https:\/\/doi.org\/10.1210\/en.2010-0754","journal-title":"Endocrinology"},{"key":"3581_CR20","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1161\/CIRCRESAHA.109.201186","volume":"105","author":"C D\u2019Aniello","year":"2009","unstructured":"D\u2019Aniello C, Lonardo E, Iaconis S, Guardiola O, Liguoro AM, Liguori GL, Autiero M, Carmeliet P, Minchiotti G (2009) G protein-coupled receptor APJ and its ligand apelin act downstream of Cripto to specify embryonic stem cells toward the cardiac lineage through extracellular signal-regulated kinase\/p70S6 kinase signaling pathway. Circ Res 105:231\u2013238. \n                    https:\/\/doi.org\/10.1161\/CIRCRESAHA.109.201186","journal-title":"Circ Res"},{"key":"3581_CR21","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1016\/j.bbagen.2017.05.017","volume":"1861","author":"K Shin","year":"2017","unstructured":"Shin K, Chapman NA, Sarker M, Kenward C, Huang SK, Weatherbee-Martin N, Pandey A, Dupre DJ, Rainey JK (2017) Bioactivity of the putative apelin proprotein expands the repertoire of apelin receptor ligands. Biochim Biophys Acta Gen Subj 1861:1901\u20131912. \n                    https:\/\/doi.org\/10.1016\/j.bbagen.2017.05.017","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"3581_CR22","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1161\/HYPERTENSIONAHA.117.10156","volume":"70","author":"ZZ Zhang","year":"2017","unstructured":"Zhang ZZ, Wang W, Jin HY, Chen X, Cheng YW, Xu YL, Song B, Penninger JM, Oudit GY, Zhong JC (2017) Apelin is a negative regulator of angiotensin II-mediated adverse myocardial remodeling and dysfunction. Hypertension 70:1165\u20131175. \n                    https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.117.10156","journal-title":"Hypertension"},{"key":"3581_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2011.34","author":"B Zheng","year":"2011","unstructured":"Zheng B, Han M, Shu YN, Li YJ, Miao SB, Zhang XH, Shi HJ, Zhang T, Wen JK (2011) HDAC2 phosphorylation-dependent Klf5 deacetylation and RARalpha acetylation induced by RAR agonist switch the transcription regulatory programs of p21 in VSMCs. Cell Res. \n                    https:\/\/doi.org\/10.1038\/cr.2011.34","journal-title":"Cell Res"},{"key":"3581_CR24","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1042\/BJ20130418","volume":"456","author":"XR Lv","year":"2013","unstructured":"Lv XR, Zheng B, Li SY, Han AL, Wang C, Shi JH, Zhang XH, Liu Y, Li YH, Wen JK (2013) Synthetic retinoid Am 80 up-regulates apelin expression by promoting interaction of RARalpha with KLF5 and Sp1 in vascular smooth muscle cells. Biochem J 456:35\u201346. \n                    https:\/\/doi.org\/10.1042\/BJ20130418","journal-title":"Biochem J"},{"key":"3581_CR25","doi-asserted-by":"publisher","first-page":"e0189223","DOI":"10.1371\/journal.pone.0189223","volume":"12","author":"C Baciu","year":"2017","unstructured":"Baciu C, Pasini E, Angeli M, Schwenger K, Afrin J, Humar A, Fischer S, Patel K, Allard J, Bhat M (2017) Systematic integrative analysis of gene expression identifies HNF4A as the central gene in pathogenesis of non-alcoholic steatohepatitis. PLoS ONE 12:e0189223. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0189223","journal-title":"PLoS ONE"},{"key":"3581_CR26","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jnutbio.2016.10.007","volume":"40","author":"M Ichimura","year":"2017","unstructured":"Ichimura M, Masuzumi M, Kawase M, Sakaki M, Tamaru S, Nagata Y, Tanaka K, Suruga K, Tsuneyama K, Matsuda S, Omagari K (2017) A diet-induced Sprague-Dawley rat model of nonalcoholic steatohepatitis-related cirrhosis. J Nutr Biochem 40:62\u201369. \n                    https:\/\/doi.org\/10.1016\/j.jnutbio.2016.10.007","journal-title":"J Nutr Biochem"},{"key":"3581_CR27","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/nm.4453","volume":"24","author":"P Zhang","year":"2018","unstructured":"Zhang P, Wang PX, Zhao LP, Zhang X, Ji YX, Zhang XJ, Fang C, Lu YX, Yang X, Gao MM, Zhang Y, Tian S, Zhu XY, Gong J, Ma XL, Li F, Wang Z, Huang Z, She ZG, Li H (2018) The deubiquitinating enzyme TNFAIP3 mediates inactivation of hepatic ASK1 and ameliorates nonalcoholic steatohepatitis. Nat Med 24:84\u201394. \n                    https:\/\/doi.org\/10.1038\/nm.4453","journal-title":"Nat Med"},{"key":"3581_CR28","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.jhep.2016.11.017","volume":"66","author":"BL Woolbright","year":"2017","unstructured":"Woolbright BL, Jaeschke H (2017) Role of the inflammasome in acetaminophen-induced liver injury and acute liver failure. J Hepatol 66:836\u2013848. \n                    https:\/\/doi.org\/10.1016\/j.jhep.2016.11.017","journal-title":"J Hepatol"},{"key":"3581_CR29","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1053\/j.gastro.2012.07.011","volume":"143","author":"RT Chung","year":"2012","unstructured":"Chung RT, Stravitz RT, Fontana RJ, Schiodt FV, Mehal WZ, Reddy KR, Lee WM (2012) Pathogenesis of liver injury in acute liver failure. Gastroenterology 143:e1\u2013e7. \n                    https:\/\/doi.org\/10.1053\/j.gastro.2012.07.011","journal-title":"Gastroenterology"},{"key":"3581_CR30","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1080\/01926230701584163","volume":"35","author":"SK Ramaiah","year":"2007","unstructured":"Ramaiah SK, Jaeschke H (2007) Role of neutrophils in the pathogenesis of acute inflammatory liver injury. Toxicol Pathol 35:757\u2013766. \n                    https:\/\/doi.org\/10.1080\/01926230701584163","journal-title":"Toxicol Pathol"},{"key":"3581_CR31","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ymgme.2016.07.012","volume":"119","author":"H Hu","year":"2016","unstructured":"Hu H, He L, Li L, Chen L (2016) Apelin\/APJ system as a therapeutic target in diabetes and its complications. Mol Genet Metab 119:20\u201327. \n                    https:\/\/doi.org\/10.1016\/j.ymgme.2016.07.012","journal-title":"Mol Genet Metab"},{"key":"3581_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2015.10.102","volume":"244","author":"X Han","year":"2016","unstructured":"Han X, Wang LY, Diao ZL, Liu WH (2016) Apelin: a novel inhibitor of vascular calcification in chronic kidney disease. Atherosclerosis 244:1\u20138. \n                    https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.10.102","journal-title":"Atherosclerosis"},{"key":"3581_CR33","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3389\/fphys.2015.00115","volume":"6","author":"C Bertrand","year":"2015","unstructured":"Bertrand C, Valet P, Castan-Laurell I (2015) Apelin and energy metabolism. Front Physiol 6:115. \n                    https:\/\/doi.org\/10.3389\/fphys.2015.00115","journal-title":"Front Physiol"},{"key":"3581_CR34","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nature23477","volume":"548","author":"SJ Patel","year":"2017","unstructured":"Patel SJ, Sanjana NE, Kishton RJ, Eidizadeh A, Vodnala SK, Cam M, Gartner JJ, Jia L, Steinberg SM, Yamamoto TN, Merchant AS, Mehta GU, Chichura A, Shalem O, Tran E, Eil R, Sukumar M, Guijarro EP, Day CP, Robbins P, Feldman S, Merlino G, Zhang F, Restifo NP (2017) Identification of essential genes for cancer immunotherapy. Nature 548:537\u2013542. \n                    https:\/\/doi.org\/10.1038\/nature23477","journal-title":"Nature"},{"key":"3581_CR35","first-page":"5313","volume":"34","author":"J Muto","year":"2014","unstructured":"Muto J, Shirabe K, Yoshizumi T, Ikegami T, Aishima S, Ishigami K, Yonemitsu Y, Ikeda T, Soejima Y, Maehara Y (2014) The apelin-APJ system induces tumor arteriogenesis in hepatocellular carcinoma. Anticancer Res 34:5313\u20135320","journal-title":"Anticancer Res"},{"key":"3581_CR36","doi-asserted-by":"publisher","first-page":"21061","DOI":"10.1074\/jbc.M908417199","volume":"275","author":"M Hosoya","year":"2000","unstructured":"Hosoya M, Kawamata Y, Fukusumi S, Fujii R, Habata Y, Hinuma S, Kitada C, Honda S, Kurokawa T, Onda H, Nishimura O, Fujino M (2000) Molecular and functional characteristics of APJ tissue distribution of mRNA and interaction with the endogenous ligand apelin. J Biol Chem 275:21061\u201321067. \n                    https:\/\/doi.org\/10.1074\/jbc.M908417199","journal-title":"J Biol Chem"},{"key":"3581_CR37","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/liv.12006","volume":"33","author":"H Yasuzaki","year":"2013","unstructured":"Yasuzaki H, Yoshida S, Hashimoto T, Shibata W, Inamori M, Toya Y, Tamura K, Maeda S, Umemura S (2013) Involvement of the apelin receptor APJ in Fas-induced liver injury. Liver Int 33:118\u2013126. \n                    https:\/\/doi.org\/10.1111\/liv.12006","journal-title":"Liver Int"},{"key":"3581_CR38","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1172\/JCI66028","volume":"123","author":"D Schuppan","year":"2013","unstructured":"Schuppan D, Kim YO (2013) Evolving therapies for liver fibrosis. J Clin Invest 123:1887\u20131901. \n                    https:\/\/doi.org\/10.1172\/JCI66028","journal-title":"J Clin Invest"},{"key":"3581_CR39","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1096\/fj.04-1930fje","volume":"18","author":"B Masri","year":"2004","unstructured":"Masri B, Morin N, Cornu M, Knibiehler B, Audigier Y (2004) Apelin (65\u201377) activates p70 S6 kinase and is mitogenic for umbilical endothelial cells. FASEB J 18:1909\u20131911. \n                    https:\/\/doi.org\/10.1096\/fj.04-1930fje","journal-title":"FASEB J"},{"key":"3581_CR40","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.lfs.2017.09.044","volume":"191","author":"F Rostamzadeh","year":"2017","unstructured":"Rostamzadeh F, Najafipour H, Yeganeh-Hajahmadi M, Esmaeili-Mahani S, Joukar S, Iranpour M (2017) Heterodimerization of apelin and opioid receptors and cardiac inotropic and lusitropic effects of apelin in 2K1C hypertension: role of pERK1\/2 and PKC. Life Sci 191:24\u201333. \n                    https:\/\/doi.org\/10.1016\/j.lfs.2017.09.044","journal-title":"Life Sci"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-019-03581-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11010-019-03581-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-019-03581-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T23:35:37Z","timestamp":1593646537000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11010-019-03581-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,3]]},"references-count":40,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["3581"],"URL":"https:\/\/doi.org\/10.1007\/s11010-019-03581-0","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,3]]},"assertion":[{"value":"14 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}